Table 1.
Clinical characteristics of Merkel cell carcinoma (MCC) patients.
| Clinical Characteristics | N (%) |
|---|---|
| Gender | |
| Female | 7 (58.3) |
| Male | 5 (41.7) |
| Age (Years) | |
| ≤65 | 4 (33.3) |
| >65 | 8 (66.7) |
| Primary Location | |
| Head and/or Neck | 2 (16.7) |
| Trunk | 4 (33.3) |
| Extremities | 6 (50.0) |
| Stage (AJCC 2019) at Molecular Analysis | |
| I | 2 (16.7) |
| II A | 4 (33.3) |
| II B | 1 (8.3) |
| III B | 3 (25.0) |
| IV | 2 (16.7) |
| Multidisciplinary Treatment | |
| Surgical excision | 12 (100.0) |
| Radiation therapy | 2 (16.7) |
| Melphalan IPLP | 3 (25.0) |
| Systemic chemotherapy | 2 (16.7) |
| Immune checkpoint inhibitors | 2 (16.7) |
| Status | |
| Dead | 10 (83.3) |
| Alive | 2 (16.7) |